Comparison
Hydrafinil vs Modafinil
Short, sharp eugeroic (Hydrafinil) vs. marathon wake-promotion (Modafinil).
Hydrafinil
Eugeroic / Wakefulness-Promoting Agent
Nootropict½ 4–6 hours (subjective; no published serum t½)
Modafinil
Eugeroic / Wakefulness-Promoting Agent
Nootropict½ 12–15 hours
Effectiveness Profile
Hydrafinil
Modafinil
At a Glance
| Hydrafinil | Modafinil | |
|---|---|---|
| Type | Nootropic | Nootropic |
| Legal status | Research | Schedule-III |
| Half-life | 4–6 hours (subjective; no published serum t½) | 12–15 hours |
| Preferred route | Oral | Oral |
| Dose frequency | as-needed | once-daily |
| Beginner dose | 25–50 mg | 50–100 mg |
| Intermediate dose | 50–100 mg | 100–200 mg |
| Advanced dose | 100–150 mg | 200–300 mg |
| Cycle length | 1–3 wks | 1–12 wks |
| Bioavailability | — | 90% |
| Time to peak | 1h | 3h |
| Active duration | 5h | 12h |
| Storage | Room temperature, dry, protected from light | Room temperature, dry, away from light |
| PCT required | No | No |
| Ancillaries required | No | No |
| Safe for women | Yes | Yes |
Verdict
Hydrafinil wins for:
- Rapid onset and shorter 4-6 hour window; ideal when evening sleep architecture matters
- Lower impact on appetite and less pronounced crash compared to classic stims (and even modafinil)
- Minimal CYP450 interaction; safer around SSRIs and hormonal stacks
- Cleaner subjective stimulation—rarely produces irritability or anxiety at standard doses
Modafinil wins for:
- Reliable, sustained 10–12h wakefulness; proven efficacy for shiftwork, contest prep, and anything demanding all-day output
- Heavier evidence base on safety, effectiveness, and side-effects
- Legal prescription status and established generics in many markets
- Noticeable impact on motivation, task persistence, and appetite suppression in caloric deficits
- Supported by large-scale meta-analyses and over two decades of real-world community use
Pick A or B?
Pick Hydrafinil if:
- The goal is a single deep-work session, focused study, or cognitive task with no evening hangover
- Managing sleep quality, insomnia, or evening cortisol is a priority
- The researcher is stacking SSRIs or other CYP2C19-metabolized compounds
- Response to modafinil has flattened due to tolerance, or side-effects are limiting
- Appetite suppression is only a minor requirement
Pick Modafinil if:
- Long-duration vigilance (e.g., night shift, exam marathons, all-day productivity sprints) is mandatory
- Appetite suppression on a deficit or prep cycle is critical
- Maximum motivation and task persistence is prioritized
- Track record, large literature, and dose reliability are more important than experimental compounds
- Modafinil is readily sourced or prescription-access is not an obstacle
This comparison is presented for informational and educational purposes only. The compounds described may be research chemicals, prescription-only, or regulated substances in your jurisdiction. Consult a qualified medical professional before using any compound. This is not medical advice.